Cardiac adverse events of immune checkpoint inhibitors in oncology patients: A systematic review and meta-analysis

BACKGROUND: Immune checkpoint inhibitors (ICIs) are novel therapeutic agents used for various types of cancer. ICIs have revolutionized cancer treatment and improved clinical outcomes among cancer patients. However, immune-related adverse effects of ICI therapy are common. Cardiovascular immune-rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Nso, Nso, Antwi-Amoabeng, Daniel, Beutler, Bryce D, Ulanja, Mark B, Ghuman, Jasmine, Hanfy, Ahmed, Nimo-Boampong, Joyce, Atanga, Sirri, Doshi, Rajkumar, Enoru, Sostanie, Gullapalli, Nageshwara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701899/
https://www.ncbi.nlm.nih.gov/pubmed/33312443
http://dx.doi.org/10.4330/wjc.v12.i11.584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701899/
https://www.ncbi.nlm.nih.gov/pubmed/33312443
http://dx.doi.org/10.4330/wjc.v12.i11.584

Ejemplares similares